Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Zynex's annualizedGross Profit for the quarter that ended in Dec. 2023 was $148.1 Mil.
Zynex's average Total Assets over the quarter that ended in Dec. 2023 was $144.2 Mil. Therefore, Zynex's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2023 was 102.70%.
Zynex Gross-Profit-to-Asset % Historical Data
The historical data trend for Zynex's Gross-Profit-to-Asset % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Zynex's Gross-Profit-to-Asset %
For the Medical Distribution subindustry, Zynex's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Zynex's Gross-Profit-to-Asset % Distribution in the Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Zynex's Gross-Profit-to-Asset % distribution charts can be found below:
* The bar in red indicates where Zynex's Gross-Profit-to-Asset % falls into.
Zynex Gross-Profit-to-Asset % Calculation
Zynex's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2023 is calculated as:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data,
the Gross Profit data used here is four times the quarterly (Dec. 2023) data.
Gross-Profit-to-Asset % is displayed in the 30-year financial page.
Zynex Gross-Profit-to-Asset % Related Terms
Thank you for viewing the detailed overview of Zynex's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.
Zynex Inc is engaged in the manufacturing and marketing of medical devices. It operates through one primary business segment, Electrotherapy and Pain Management Products. The business activities of the company are carried out through its subsidiaries. The company designs, manufacture, and markets medical devices that treat chronic and acute pain, as well as activate and exercise muscles for rehabilitative purposes with electrical stimulation. it also develops and markets medical devices for non-invasive cardiac monitoring, the products of which are under development. The company markets Zynex-manufactured products which include NexWave, NeuroMove, InWave E-Wave and others.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ZYXI has been successfully added to your 